Alpha Tau Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alpha Tau Medical (DRTS).

Price Target Range — 13 Quarters

Analyst Consensus — 5 Analysts

4Buy

1Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$14Upside to Avg. PT+7.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 20, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$16
Sep 3, 2026	Barclays	Lukas Shumway	PT Raise	Overweight	$17→$30
Aug 11, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$15→$16
Jul 22, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$15
Jul 16, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$15
Jun 4, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$15
Jun 4, 2026	Barclays	Lukas Shumway	PT Raise	Overweight	$15→$17
Jun 2, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$15
May 28, 2026	Barclays	Lukas Shumway	Initiate	Overweight	$15
May 20, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$15
May 19, 2026	Piper Sandler	Jason Bednar	PT Raise	Neutral	$5→$8
May 12, 2026	Ladenburg Thalmann	Jeff Cohen	PT Raise	Buy	$12→$14
May 12, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$12→$15
Mar 11, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$7→$9
Mar 10, 2026	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$12
Mar 4, 2026	Piper Sandler	Jason Bednar	Downgrade	Overweight→Neutral	$5
Feb 24, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$9→$12
Dec 10, 2025	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$8→$7
Nov 24, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$9
Oct 22, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$9

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $16 price target.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Alpha Tau Medical, Raises Price Target to $30

Barclays analyst Lukas Shumway maintains Alpha Tau Medical (NASDAQ:DRTS) with a Overweight and raises the price target from $17 to $30.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $16

HC Wainwright & Co. analyst Yi Chen maintains Alpha Tau Medical (NASDAQ:DRTS) with a Buy and raises the price target from $15 to $16.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $15 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Alpha Tau Medical (NASDAQ:DRTS) with a Buy and maintains $15 price target.

Benzinga Newsdesk

Alpha Tau Medical Ltd

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Alpha Tau Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target

PRO
Barclays Maintains Overweight on Alpha Tau Medical, Raises Price Target to $30

PRO
HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $16

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

People Also Watch

People Also Watch

Alpha Tau Medical Ltd

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Alpha Tau Medical Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target

PROBarclays Maintains Overweight on Alpha Tau Medical, Raises Price Target to $30

PROHC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $16

PROHC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

PROHC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

PROHC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $16 Price Target

PRO
Barclays Maintains Overweight on Alpha Tau Medical, Raises Price Target to $30

PRO
HC Wainwright & Co. Maintains Buy on Alpha Tau Medical, Raises Price Target to $16

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $15 Price Target